Periventricular Leukomalacia
What's New
Last Posted: Jan 09, 2024
- Genetic variants in the HLA region contribute to the risk of cerebral palsy.
Ye Cheng, et al. Biochimica et biophysica acta. Molecular basis of disease 2024 0 (3) 167008 - Identifying of 22q11.2 variations in Chinese patients with development delay.
Zhang Yuanyuan, et al. BMC medical genomics 2021 0 (1) 26 - A Genome-Wide Analysis of Clinical Chorioamnionitis among Preterm Infants.
Spiegel Ariana M, et al. American journal of perinatology 2019 1 - The association between pro- and anti-inflammatory cytokine polymorphisms and periventricular leukomalacia in newborns with hypoxic-ischemic encephalopathy.
Gabriel Marta Lúcia, et al. Journal of inflammation research 2016 0 59-67 - The role of prothrombotic factors in children with hemiplegic cerebral palsy.
Türedi Yildirim A, et al. Minerva pediatrica 2015 8 (4) 279-284 - The association between sex-related interleukin-6 gene polymorphisms and the risk for cerebral palsy.
Bi Dan, et al. Journal of neuroinflammation 2014 0 (1) 100 - Interleukin-6 polymorphism and bronchopulmonary dysplasia risk in very low-birthweight infants.
Usuda Touhei, et al. Pediatrics international : official journal of the Japan Pediatric Society 2012 8 (4) 471-5 - The association between proinflammatory cytokine polymorphisms and cerebral palsy in very preterm infants.
Kapitanovi? Vidak Helena, et al. Cytokine 2012 4 (1) 57-64 - Periventricular leukomalacia
From NCATS Genetic and Rare Diseases Information Center - Mannose-binding lectin gene polymorphism and early neonatal outcome in preterm infants.
Koroglu Ozge Altun, et al. Neonatology 2010 0 (4) 305-12 - Maternal interleukin-6 (-174) C/C polymorphism is associated with chorioamnionitis and cystic periventricular leucomalacia of the preterm infant.
Resch B, et al. Journal of perinatology : official journal of the California Perinatal Association 2010 11 (11) 712-6 - Interleukin-6 G(--174)C polymorphism is associated with mental retardation in cystic periventricular leucomalacia in preterm infants.
Resch B, et al. Archives of disease in childhood. Fetal and neonatal edition 2009 7 (4) F304-6 - Genetic polymorphisms of hemostasis genes and primary outcome of very low birth weight infants.
Härtel Christoph, et al. Pediatrics 2006 8 (2) 683-9 - Does interleukin-6 genotype influence cerebral injury or developmental progress after preterm birth?
Harding David R, et al. Pediatrics 2004 10 (4) 941-7 - Interleukin-10 -1082 G/A polymorphism and risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infants.
Yanamandra Krishna, et al. Pediatric pulmonology 2005 5 (5) 426-32 - Interleukin-6-174-genotype, sepsis and cerebral injury in very low birth weight infants.
Göpel W, et al. Genes and immunity 2006 1 (1) 65-8 - The Angiotensin Converting Enzyme Insertion/Deletion polymorphism is not associated with an increased risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infants.
Yanamandra Krishna, et al. BMC pediatrics 2004 0 (1) 26 - Tumor necrosis factor-alpha allele lymphotoxin-alpha+250 is associated with the presence and severity of placental inflammation among preterm births.
Kazzi S Nadya J, et al. Pediatric research 2004 7 (1) 94-8
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: